2025 EVENT SITE
WMIF MAIN SITETuesday, September 16, 2025
01:00 PM - 01:40 PM
For decades, diagnostics have required data generation and then interpretation. Computational approaches, however, could generate new diagnostics from *existing* data - images, radiology, EEGs, and genomics. This panel will delve into advancements in AI-driven diagnostic tools, emphasizing their ability to analyze complex data sets and predict clinical outcomes with unprecedented accuracy. Panelists will discuss how "in silico" diagnostics are transforming traditional workflows, improving early detection, and enabling more personalized approaches to patient care. The conversation will also address the challenges of scaling these technologies, including regulatory hurdles, integration into existing healthcare systems, and reimbursement.
Moderator
Danielle Bitterman, MD,
Radiation Oncologist, Brigham and Women's Hospital;
Assistant Professor of Radiation Oncology, Harvard Medical School
Speakers
Andy Beck, MD, PhD,
CEO, PathAI
Jacob Donoghue, MD, PhD,
CEO, Beacon Biosignals
Connie Lehman, MD, PhD,
Founder, Clairity;
Professor of Radiology, Harvard Medical School
Jay Rughani,
Investing Partner, Andreessen Horowitz
David Spetzler, PhD,
President, Caris Life Sciences